David Shaw’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.97M | Buy |
+10,000
| New | +$4.43M | ﹤0.01% | 2410 |
|
|
2026
Q1 | – | Sell |
-33,100
| Closed | -$15M | – | 5105 |
|
|
2025
Q4 | $15M | Sell |
33,100
-2,500
| -7% | -$1.08M | 0.01% | 1436 |
|
|
2025
Q3 | $13.9M | Buy |
35,600
+32,000
| +889% | +$13.4M | 0.01% | 1425 |
|
|
2025
Q2 | $1.6M | Sell |
3,600
-9,200
| -72% | -$4.24M | ﹤0.01% | 2907 |
|
|
2025
Q1 | $6.21M | Buy |
+12,800
| New | +$5.96M | 0.01% | 1741 |
|
|
2024
Q4 | – | Sell |
-14,100
| Closed | -$6.56M | – | 4926 |
|
|
2024
Q3 | $6.56M | Buy |
14,100
+9,100
| +182% | +$4.37M | 0.01% | 1740 |
|
|
2024
Q2 | $2.34M | Sell |
5,000
-3,900
| -44% | -$1.69M | ﹤0.01% | 2520 |
|
|
2024
Q1 | $3.72M | Buy |
+8,900
| New | +$3.76M | ﹤0.01% | 2125 |
|
|
2021
Q1 | – | Sell |
-13,900
| Closed | -$3.29M | – | 4520 |
|
|
2020
Q4 | $3.29M | Hold |
13,900
| – | – | ﹤0.01% | 2199 |
|
|
2020
Q3 | $3.78M | Sell |
13,900
-600
| -4% | -$166K | ﹤0.01% | 1902 |
|
|
2020
Q2 | $4.21M | Sell |
14,500
-500
| -3% | -$136K | 0.01% | 1782 |
|
|
2020
Q1 | $3.57M | Sell |
15,000
-5,000
| -25% | -$1.15M | 0.01% | 1725 |
|
|
2019
Q4 | $4.38M | Hold |
20,000
| – | – | 0.01% | 1834 |
|
|
2019
Q3 | $3.39M | Hold |
20,000
| – | – | ﹤0.01% | 1947 |
|
|
2019
Q2 | $3.67M | Hold |
20,000
| – | – | ﹤0.01% | 1822 |
|
|
2019
Q1 | $3.68M | Hold |
20,000
| – | – | ﹤0.01% | 1755 |
|
|
2018
Q4 | $3.31M | Hold |
20,000
| – | – | ﹤0.01% | 1778 |
|
|
2018
Q3 | $3.85M | Sell |
20,000
-8,000
| -29% | -$1.42M | ﹤0.01% | 1743 |
|
|
2018
Q2 | $4.76M | Buy |
28,000
+8,000
| +40% | +$1.24M | 0.01% | 1573 |
|
|
2018
Q1 | $3.26M | Sell |
20,000
-10,000
| -33% | -$1.63M | ﹤0.01% | 1698 |
|
|
2017
Q4 | $4.5M | Hold |
30,000
| – | – | 0.01% | 1561 |
|
|
2017
Q3 | $4.56M | Buy |
30,000
+20,000
| +200% | +$3.01M | 0.01% | 1448 |
|
|
2017
Q2 | $1.29M | Hold |
10,000
| – | – | ﹤0.01% | 2254 |
|
|
2017
Q1 | $1.09M | Sell |
10,000
-16,800
| -63% | -$1.48M | ﹤0.01% | 2245 |
|
|
2016
Q4 | $1.97M | Sell |
26,800
-4,300
| -14% | -$350K | ﹤0.01% | 2018 |
|
|
2016
Q3 | $2.71M | Buy |
31,100
+4,300
| +16% | +$406K | ﹤0.01% | 1691 |
|
|
2016
Q2 | $2.31M | Hold |
26,800
| – | – | ﹤0.01% | 1828 |
|
|
2016
Q1 | $2.13M | Hold |
26,800
| – | – | ﹤0.01% | 1841 |
|
|
2015
Q4 | $3.37M | Buy |
26,800
+16,800
| +168% | +$2.03M | 0.01% | 1726 |
|
|
2015
Q3 | $1.04M | Sell |
10,000
-2,200
| -18% | -$283K | ﹤0.01% | 2590 |
|
|
2015
Q2 | $1.51M | Buy |
12,200
+2,200
| +22% | +$277K | ﹤0.01% | 2410 |
|
|
2015
Q1 | $1.18M | Sell |
10,000
-6,900
| -41% | -$827K | ﹤0.01% | 2440 |
|
|
2014
Q4 | $2.01M | Buy |
16,900
+9,300
| +122% | +$1.05M | ﹤0.01% | 2283 |
|
|
2014
Q3 | $854K | Sell |
7,600
-12,500
| -62% | -$1.19M | ﹤0.01% | 2937 |
|
|
2014
Q2 | $1.9M | Buy |
+20,100
| New | +$1.41M | ﹤0.01% | 2348 |
|
Other funds holding VRTX
David Shaw's VRTX Position: Q2 2026 in Review
David Shaw reduced its Vertex Pharmaceuticals (VRTX) stake by 99% in Q2 2026, selling an estimated $109M and leaving 3,105 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3417.
David Shaw first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $311M in Q3 2021. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- David Shaw held 3,105 shares of Vertex Pharmaceuticals worth $1.54M as of Q2 2026.
- David Shaw sold 245,855 Vertex Pharmaceuticals shares in Q2 2026, an estimated $109M.
- Vertex Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3417 holding.
- David Shaw first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- David Shaw's Vertex Pharmaceuticals position peaked at $311M in Q3 2021.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.